Dodecylguanidine Suspension Concentrate Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current fungicidal suspension concentrates of dodecylguanidine are limited in concentration, stability, and ecological profile, leading to high transportation costs and potential environmental impact, with existing surfactants being incompatible with dodecylguanidine.

Innovation Solution

An aqueous suspension concentrate with a median particle diameter of at least 7 μm and up to 40 μm, using non-ionic surfactants and a higher active ingredient content, which maintains stability and efficacy while reducing environmental impact.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If the concentration of active ingredient in suspension concentrate is increased, then transportation cost and packaging complexity are reduced, but the formulation becomes unstable and particles settle

Engineering Contradiction:
Improveconcentration of active ingredientVSAvoidstability of suspension concentrate
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent changes the particle size parameter from conventional fine particles (<5 μm) to larger particles (7-40 μm median diameter). This parameter change allows significantly higher active ingredient concentration (544 g/l vs. typical 400 g/l) while maintaining suspension stability and preventing particle settling, thus resolving the contradiction between concentration and stability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite formulation system combining dodecylguanidine acetate with specific non-ionic surfactants and thickening agents. This composite approach creates a stable highly concentrated suspension where the surfactant-wetted larger particles remain dispersed uniformly, achieving both high concentration (544 g/l) and long-term storage stability

Inventive Principle:
Principle #40Composite materials

2Reliability

If particle size of active ingredient is reduced to increase surface area, then chemical activity is improved, but concentration is limited due to stability requirements

Engineering Contradiction:
Improvechemical activityVSAvoidconcentration of active ingredient
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent inverts the conventional particle size approach by using larger particles (7-40 μm median diameter instead of <5 μm). This counterintuitive parameter change, combined with non-ionic surfactant treatment, maintains sufficient chemical activity while enabling much higher concentration levels (544 g/l vs. typical formulations), thus resolving the contradiction between chemical activity and concentration

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If conventional surfactants are used to improve wetting properties, then particle dispersion is improved, but compatibility with dodecylguanidine is poor

Engineering Contradiction:
Improvewetting propertiesVSAvoidcompatibility with dodecylguanidine
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent changes the surfactant type parameter from conventional anionic or cationic surfactants to non-ionic surfactants. This parameter change resolves the compatibility issue with dodecylguanidine acetate while still providing effective wetting and dispersion properties for the active ingredient particles in the suspension concentrate formulation

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulation achieves higher concentration, stability, and reduced toxicity, maintaining or improving efficacy against fungal diseases, and simplifying handling and storage with increased particle size.

Implementation Method 1

Formulators have introduced surfactants into suspension concentrates to improve wetting properties to keep the active ingredient particles dispersed in the liquid phase

Methodology Applied
Scientific EffectSurfactant: Surfactant

Implementation Method 2

improve wetting properties to keep the active ingredient particles dispersed

Methodology Applied
Scientific EffectWetting: Wetting

Implementation Method 3

An aqueous suspension concentrate with a median particle diameter of at least 7 μm and up to 40 μm, using non-ionic surfactants and a higher active ingredient content, which maintains stability and efficacy

Methodology Applied
Scientific EffectSuspension: Suspension

Data Source

PatentUS11006627B2Aqueous suspension concentrate comprising an acid salt of dodecylguanidine
Publication Date: 2021.05.18 ARYSTA LIFESCI BENELUX
  • US11006627B2 patent drawing
  • US11006627B2 patent drawing
  • US11006627B2 patent drawing

AI summary

The invention concerns a suspension concentrate comprising, expressed by weight based on the total weight of the composition: a) 40 to 80% particles of dodecylguanidine or an acid salt of dodecylguanidine of the structure (1), wherein X represents an acid residue of a monocarboxylic, dicarboxylic or a mineral acid, b) 0 to 10% of an anti-freeze compound, c) 1 to 10% of a wetting agent and/or d) a dispersing agent, e) 0 to 5% of an antifoaming agent, f) remainder water characterized in that, the median diameter of the particles (d50) is at least 7 μm and below 40 μm; and its use for the treatment of a fungicidal disease on crops or ornamental plants.